Therefore, while the anti-inflammatory potential of nutrients such as polyphenols may be difficult to translate in the clinical trial setting, the success of salicylate highlights the potential of therapies which target IKKβ/NF-κB inhibition in terms of attenuating metabolic-inflammation and insulin resistance [60,98]. This evidence concerns the gene NFKB1 and Insulin resistance.